← Back to headlines
BioMarin Stock Rises Following Positive Voxzogo Phase 3 Trial Results
BioMarin Pharmaceutical's stock saw gains after the company announced positive results from the Phase 3 clinical trial of its drug, Voxzogo.
20 May, 22:09 — 20 May, 22:09
Sources
Showing 1 of 1 sources
